Garth Joseph McGrath

Title: Garth Joseph McGrath: Innovator in Genetic Modulation

Introduction

Garth Joseph McGrath is a notable inventor based in San Rafael, CA. He has made significant contributions to the field of genetic modulation, particularly in relation to the PTEN pathway and presenilin enhancers. With a total of 2 patents, his work has implications for therapeutic targets and biopharmaceutical applications.

Latest Patents

McGrath's latest patents include "Marks as Modifiers of the PTEN Pathway and Methods of Use" and "Presenilin Enhancers Assays." The first patent identifies human MARK genes as modulators of the PTEN pathway, highlighting their potential as therapeutic targets for disorders associated with defective PTEN function. It also provides methods for identifying modulators of PTEN by screening for agents that influence MARK activity. The second patent offers methods and compositions related to pen polypeptides, including isolated pen hybridization probes and primers. These innovations are crucial for diagnosis, therapy, and the biopharmaceutical industry.

Career Highlights

Garth McGrath is currently associated with Exelixis, Inc., where he continues to advance his research in genetic modulation. His work has garnered attention for its potential to impact various medical fields, particularly in understanding and treating genetic disorders.

Collaborations

Throughout his career, McGrath has collaborated with notable colleagues such as Kim Lickteig and Sharmon Monique Nicoll. These partnerships have contributed to the development of his innovative patents and research.

Conclusion

Garth Joseph McGrath stands out as an influential inventor in the realm of genetic modulation. His patents and ongoing research at Exelixis, Inc. reflect his commitment to advancing medical science and improving therapeutic strategies.